Abstract:Objective: To systematically evaluate the efficacy and safety of radiofrequency ablation and liver resection in the therapeutic management of early-stage hepatocellular carcinoma. Method: We conducted a comprehensive search of domestic and foreign databases including PubMed, Web of Science, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), and Wanfang to retrieve literature on radiofrequency ablation and liver resection for the treatment of early hepatocellular carcinoma. The retrieved literature underwent thorough screening, and relevant data were extracted. Following the evaluation of the literature's quality, Meta-analysis was performed using RevMan 5.4 software. Results: In this study, a total of 11 documents were selected, comprising 1334 patients with hepatocellular carcinoma. Meta-analysis results indicated that there was no statistically significant difference in the 1-year overall survival rate [Relative risk (RR) = 1.01, 95% confidence intervals (CI) (0.98; 1.04)] and the 3-year overall survival rate [RR = 0.95, 95% CI (0.90; 1.01)] between the radiofrequency ablation and liver resection groups (p > 0.05). Similarly, there was no statistically significant difference in the 1-year disease-free survival rate [RR = 0.94, 95% CI (0.87; 1.01)] between the two groups. However, the 3-year disease-free survival rate [RR = 0.84, 95% CI (0.74; 0.96)] of patients in the radiofrequency ablation group was significantly lower than that in the hepatectomy group (p < 0.05). Notably, the incidence of complications [RR = 0.42, 95% CI (0.33; 0.55)] was significantly lower in the radiofrequency ablation group compared to the hepatectomy group. Conversely, the local recurrence rate [RR = 1.45, 95% CI (1.22; 1.73)] was significantly higher in the radiofrequency ablation group compared to the hepatectomy group (p < 0.05). Conclusion: During the treatment of hepatocellular carcinoma, hepatectomy demonstrates superior clinical efficacy compared to radiofrequency ablation, particularly in its ability to control tumor recurrence. However, radiofrequency ablation presents with fewer complications and a higher level of safety. These findings can serve as a valuable foundation for clinicians when selecting the most suitable treatment approaches for liver cancer.

Network Meta-analysis on the Efficacy and Safety of Surgical Resection and Thermal Ablations for Hepatocellular Carcinoma in China

Surgical Resection Plus Radiofrequency Ablation Versus Radical Surgery for Hepatocellular Carcinoma: A Propensity Score Matching Analysis.

Comparative Efficacy of Treatment Strategies for Hepatocellular Carcinoma: Systematic Review and Network Meta-Analysis.

Efficacy of Radiofrequency Ablation Versus Laparoscopic Liver Resection for Hepatocellular Carcinoma in China: a Comprehensive Meta-Analysis

Comparison of Cooled-Probe Microwave and Radiofrequency Ablation Treatment in Incipient Hepatocellular Carcinoma: A Phase Iii Randomized Controlled Trial with 6-Year Follow-Up

Ablative Treatments and Surgery for Early-Stage Hepatocellular Carcinoma: A Network Meta-Analysis

Effectiveness and Safety of Radiofrequency Ablation versus Liver Resection in the Treatment of Early-stage Hepatocellular Carcinoma: A Systematic Review and Meta-analysis

Comparison of Percutaneous Microwave Ablation and Surgical Resection for Hepatocellular Carcinoma in the Caudate Lobe

Efficacy and safety of B-ultrasound-guided radiofrequency ablation in the treatment of primary liver cancer: Systematic review and meta-analysis

Survival comparison between radiofrequency ablation and surgical resection for patients with small hepatocellular carcinoma A systematic review and meta-analysis

Comparative Efficacy and Safety Between Ablative Therapies or Surgery for Small Hepatocellular Carcinoma: a Network Meta-Analysis.

Radiofrequency Ablation Versus Hepatic Resection for Small Hepatocellular Carcinoma: a Meta-Analysis of Randomized Controlled Trials.

Percutaneous radiofrequency ablation combined with transarterial chemoembolization versus surgical resection in the treatment for early-stage hepatocellular carcinoma:a Meta-analysis

Efficacy and Safety of Microwave Ablation and Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

Radiofrequency Ablation Versus Surgical Resection for Intrahepatic Hepatocellular Carcinoma Recurrence: a Meta-Analysis

Percutaneous ablation therapy versus surgical resection in the treatment for early-stage hepatocellular carcinoma: a meta-analysis of 21,494 patients

Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis

Survival Comparison Between Radiofrequency Ablation and Surgical Resection for Patients with Small Hepatocellular Carcinoma

Radiofrequency Ablation Versus Surgical Resection for the Treatment of Hepatocellular Carcinoma-a Meta Analysis

Hepatic resection combined with radiofrequency ablation versus hepatic resection alone for multifocal hepatocellular carcinomas: A meta-analysis

Radiofrequency Ablation Vs. Surgical Resection for Resectable Hepatocellular Carcinoma: A Systematic Review and Meta‑analysis